- Home
- LIDR vs PLRX Comparison
LIDR vs PLRX Comparison
Compare LIDR & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- PLRX
- Stock Information
- Founded
- LIDR 2013
- PLRX 2015
- Country
- LIDR United States
- PLRX United States
- Employees
- LIDR N/A
- PLRX N/A
- Industry
- LIDR Auto Parts:O.E.M.
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- PLRX Health Care
- Exchange
- LIDR Nasdaq
- PLRX Nasdaq
- Market Cap
- LIDR 105.4M
- PLRX 93.3M
- IPO Year
- LIDR N/A
- PLRX 2020
- Fundamental
- Price
- LIDR $2.43
- PLRX $1.57
- Analyst Decision
- LIDR Strong Buy
- PLRX Hold
- Analyst Count
- LIDR 1
- PLRX 11
- Target Price
- LIDR $6.00
- PLRX $3.79
- AVG Volume (30 Days)
- LIDR 2.1M
- PLRX 707.4K
- Earning Date
- LIDR 11-06-2025
- PLRX 11-06-2025
- Dividend Yield
- LIDR N/A
- PLRX N/A
- EPS Growth
- LIDR N/A
- PLRX N/A
- EPS
- LIDR N/A
- PLRX N/A
- Revenue
- LIDR $182,000.00
- PLRX N/A
- Revenue This Year
- LIDR $1.50
- PLRX N/A
- Revenue Next Year
- LIDR $2,806.06
- PLRX N/A
- P/E Ratio
- LIDR N/A
- PLRX N/A
- Revenue Growth
- LIDR N/A
- PLRX N/A
- 52 Week Low
- LIDR $0.49
- PLRX $1.10
- 52 Week High
- LIDR $6.44
- PLRX $15.80
- Technical
- Relative Strength Index (RSI)
- LIDR 47.69
- PLRX 46.13
- Support Level
- LIDR $2.28
- PLRX $1.48
- Resistance Level
- LIDR $2.54
- PLRX $1.82
- Average True Range (ATR)
- LIDR 0.20
- PLRX 0.12
- MACD
- LIDR 0.01
- PLRX -0.02
- Stochastic Oscillator
- LIDR 63.21
- PLRX 32.88
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.